Immigration and its effects on crime, social disorder and community tensions remains a pervasive feature of public, government and academic discourse. This discourse often considers immigration, and immigrants themselves, as a threat to the community's existing moral and social order. This paper presents the findings of a case study that used quantitative and qualitative methods to explore the experiences of social order following a recent wave of Polish migration in a small working class town in the North West of England. The key findings show that the assumed association of migration with a disruption to social order receives little support. Rather, the social order in the studied locale is predominantly managed and maintained through 'civilised relationships' between migrants and established residents, thus failing to culminate into conflict between the two groups. This situation of 'civility' provides an alternative to the preponderance of previous research telling a 'gloomy tale' of immigration and its impact on local communities.
ABSTRACTThe approach to the investigation of contamination is similar in both Europe and North America. However, the assessment of the resultant data can and does vary significantly. This paper seeks to address the concepts employed in contamination assessment in the UK, mainland Europe, Canada and the US. Details are presented of the relevant legislation in each country and the governmental guidance which is issued. Comparisons are made of the approach to the assessment and remediation that would be adopted for sites with identified levels of chemical contamination. The paper also looks forward and expresses views on how the approaches may progress over the next five years.
Chief Scientist's Office of the Scottish Government and Asthma UK as part of the Asthma UK Centre for Applied Research (AUK-AC-2012–01). BN is supported by the Farr Institute and Asthma UK Centre for Applied Research.
Chief Scientist's Office of the Scottish Government and Asthma UK as part of the Asthma UK Centre for Applied Research [AUK-AC-2012-01]. BN and AS are supported by the Farr Institute and Asthma UK Centre for Applied Research. ; This work is supported by the Chief Scientist's Office of the Scottish Government and Asthma UK as part of the Asthma UK Centre for Applied Research (AUK-AC-2012-01). BIN and AS are supported by the Farr Institute and Asthma UK Centre for Applied Research.
Background: UK government policy aims to strengthen the role of community pharmacies in health promotion. Thus, we conducted feasibility studies for an intervention to enhance delivery of the NHS Smoking Cessation Service. Methods: The overall aims were to assess acceptability and feasibility of conducting the intervention in community pharmacies and piloting this with a cluster randomised trial. Specific objectives were (1) to estimate likely participation rates of pharmacies and stop smoking advisors, (2) to establish the potential impact of the training intervention on throughput and retention of smokers in smoking services, (3) to establish potential impact on smoking cessation outcomes, (4) to optimise logistics for conducting a cluster randomised trial in the next phase of the research programme and (5) to consider the feasibility of collecting pharmacy and service user data. In this cluster randomised parallel group pilot trial, 12 community pharmacies in East London were allocated to intervention or usual practice using simple randomisation (allocation ratio 2:1). Data were analysed descriptively. Results: Twelve of 54 (22.2%, 95% CI 12.0% to 35.6%) pharmacies and 20 of 23 (87.0%, 95% CI 66.4% to 97.2%) advisors invited, agreed to participate. Over 5 months, 302 smokers in intervention pharmacies (mean per pharmacy 43.1, 95% CI: −4.3 to 90.5) and 319 in usual practice pharmacies (mean per pharmacy 79.8, 95% CI: 19.0 to 140.5) joined the service. 51 of 621 smokers (6.3% in intervention vs 10.0% in usual practice) consented to provide additional data on smoking cessation. 17 of 19 smokers that consented were retained at 4 weeks in intervention arm (89.5%, 95% CI: 66.9% to 98.7%) and 24 of 32 in usual practice (75.0%, 95% CI: 56.6% to 88.5%). 10 of 19 in the intervention arm (52.6%, 95% CI: 28.9% to 75.6%) stopped smoking compared to 7 of 32 in usual practice arm (21.9%, 95% CI: 9.3% to 40.0%). The pilot was useful in providing insights on how best to conduct the definitive trial and shortcomings of our ...
BACKGROUND: UK government policy aims to strengthen the role of community pharmacies in health promotion. Thus, we conducted feasibility studies for an intervention to enhance delivery of the NHS Smoking Cessation Service. METHODS: The overall aims were to assess acceptability and feasibility of conducting the intervention in community pharmacies and piloting this with a cluster randomised trial. Specific objectives were (1) to estimate likely participation rates of pharmacies and stop smoking advisors, (2) to establish the potential impact of the training intervention on throughput and retention of smokers in smoking services, (3) to establish potential impact on smoking cessation outcomes, (4) to optimise logistics for conducting a cluster randomised trial in the next phase of the research programme and (5) to consider the feasibility of collecting pharmacy and service user data. In this cluster randomised parallel group pilot trial, 12 community pharmacies in East London were allocated to intervention or usual practice using simple randomisation (allocation ratio 2:1). Data were analysed descriptively. RESULTS: Twelve of 54 (22.2%, 95% CI 12.0% to 35.6%) pharmacies and 20 of 23 (87.0%, 95% CI 66.4% to 97.2%) advisors invited, agreed to participate. Over 5 months, 302 smokers in intervention pharmacies (mean per pharmacy 43.1, 95% CI: -4.3 to 90.5) and 319 in usual practice pharmacies (mean per pharmacy 79.8, 95% CI: 19.0 to 140.5) joined the service. 51 of 621 smokers (6.3% in intervention vs 10.0% in usual practice) consented to provide additional data on smoking cessation. 17 of 19 smokers that consented were retained at 4 weeks in intervention arm (89.5%, 95% CI: 66.9% to 98.7%) and 24 of 32 in usual practice (75.0%, 95% CI: 56.6% to 88.5%). 10 of 19 in the intervention arm (52.6%, 95% CI: 28.9% to 75.6%) stopped smoking compared to 7 of 32 in usual practice arm (21.9%, 95% CI: 9.3% to 40.0%). The pilot was useful in providing insights on how best to conduct the definitive trial and shortcomings of our present logistical arrangements, including feasibility of collecting pharmacy and service user data. CONCLUSIONS: Recruitment rates show that the main trial is feasible, and the results suggest that the intervention may improve retention and quit rates in smoking cessation services. We gained insights on how best to conduct the definitive trial which will proceed as planned.
BACKGROUND: In April 2014 the UK government launched the 'NHS Visitor and Migrant Cost Recovery Programme Implementation Plan' which set out a series of policy changes to recoup costs from 'chargeable' (largely non-UK born) patients. In England, approximately 75% of tuberculosis (TB) cases occur in people born abroad. Delays in TB treatment increase risk of morbidity, mortality and transmission in the community. We investigated whether diagnostic delay has increased since the Cost Recovery Programme (CRP) was introduced. METHODS: There were 3342 adult TB cases notified on the London TB Register across Barts Health NHS Trust between 1st January 2011 and 31st December 2016. Cases with missing relevant information were excluded. The median time between symptom onset and treatment initiation before and after the CRP was calculated according to birthplace and compared using the Mann Whitney test. Delayed diagnosis was considered greater or equal to median time to treatment for all patients (79 days). Univariable logistic regression was used to manually select exposure variables for inclusion in a multivariable model to test the association between diagnostic delay and the implementation of the CRP. RESULTS: We included 2237 TB cases. Among non-UK born patients, median time-to-treatment increased from 69 days to 89 days following introduction of CRP (p < 0.001). Median time-to-treatment also increased for the UK-born population from 75.5 days to 89.5 days (p = 0.307). The multivariable logistic regression model showed non-UK born patients were more likely to have a delay in diagnosis after the CRP (adjOR 1.37, 95% CI 1.13–1.66, p value 0.001). CONCLUSION: Since the introduction of the CRP there has been a significant delay for TB treatment among non-UK born patients. Further research exploring the effect of policies restricting access to healthcare for migrants is urgently needed if we wish to eliminate TB nationally.
13 páginas, 7 figuras, 6 tablas, 8 apéndices. ; Aim Climate change is expected to drive range shifts among a wide array of organisms.Non-indigenous species (NIS) provide a unique opportunity to observe the establishment of range boundaries in a way that cannot be directly seen for native species. Recent studies have indicated that climate change facilitates biological invasions at local scales. However, the generality of these effects is unclear, as there is a dearth of comparative studies that assess how rapid environmental change affects species ranges across taxa and biogeographic provinces. Location The South African coast and other coastlines across the world. Methods We first studied the distribution of shallow-marine benthic organisms along the South African coastline and analysed the global distribution of NIS.We then obtained DNA sequence data from a suite of co-occurring NIS from along the studied coastline and compared these data with available genetic information from other regions of the world. Subsequently, we conducted physiological experiments to assess how thermal tolerance was related to species distribution. Finally, we analysed ship-based seawater temperature records and compared these with past changes in the range size and abundance of NIS. These records were used to estimate shipping intensity and NIS propagule pressure. Results We found that NIS with a variety of thermal tolerances and distributions have expanded their ranges and increased in abundance as seawater temperature regimes have changed.We found little interannual variation in shipping transport intensity. Most haplotypes of the studied NIS in South Africa were shared with other regions. Main conclusions This study provides empirical evidence that NIS, regardless of their thermal tolerance, range size and genetic variability, are expanding their ranges and increasing in abundance. This trend is uncorrelated with levels of human-mediated NIS transport but concurrent with changes in seawater temperature, which suggests that climate change fosters the spread and abundance of NIS across multiple spatial scales. ; M.R. has received funding from the Spanish 'Ministerio de Educación y Ciencia', the 'Agencia Española de Cooperación Internacional para el Desarrollo' from the Spanish'Ministerio de Asuntos Exteriores y de Cooperación'. S.C.T. was supported by the National Research Foundation Incentive Funding and the DST-NRF Centre of Excellence for Invasion Biology. The research was funded by a grant from the DST-NRF Centre of Excellence for Invasion Biology to C.L.G and M.R., the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation to C.D.M, and the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement no. PIOF-GA-2009-254634 to M.R. ; Peer reviewed
